TNIK and idiopathic pulmonary fibrosis: Whereas tyrosine kinase inhibitors like nintedanib, imatinib and nilotinib have been tested in IPF, the role of serine–threonine kinases (such as TNIK) in IPF remains largely uninterrogated (Fig. 1c).